Glycated hemoglobin is associated with the growth rate of abdominal aortic aneurysms a substudy from the VIVA (Viborg vascular) randomized screening trial

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 37, Issue 4, 2017, Pages 730-736

  Kristensen, Katrine Lawaetz ^a   Dahl, Marie ^b   Rasmussen, Lars Melholt ^a   Lindholt, Jes Sanddal ^a,b  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b The Region Hospital   (Denmark)

Author keywords

Abdominal; Aortic aneurysm; Atherosclerosis; Comorbidity; Diabetes mellitus; Hyperglycemia

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; BIOLOGICAL MARKER; HEMOGLOBIN A1C PROTEIN, HUMAN;

ABDOMINAL AORTA ANEURYSM; AGED; ARTERIAL STIFFNESS; ARTICLE; COHORT ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; ECHOGRAPHY; GLUCOSE BLOOD LEVEL; GROWTH RATE; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); AORTIC ANEURYSM, ABDOMINAL; BLOOD; COMORBIDITY; CONTROLLED STUDY; DENMARK; DIAGNOSTIC IMAGING; DISEASE COURSE; MASS SCREENING; PREDICTIVE VALUE; PREVALENCE; PROCEDURES; PROTECTION; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TIME FACTOR;

AGED; AORTIC ANEURYSM, ABDOMINAL; BIOMARKERS; COMORBIDITY; DENMARK; DIABETES MELLITUS; DISEASE PROGRESSION; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MASS SCREENING; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROTECTIVE FACTORS; RISK FACTORS; TIME FACTORS; ULTRASONOGRAPHY;

EID: 85012168810     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.116.308874     Document Type: Article

References (33)

1. Lederle FA, Johnson GR, Wilson SE, Chute EP, Littooy FN, Bandyk D, Krupski WC, Barone GW, Acher CW, Ballard DJ. Prevalence and associations of abdominal aortic aneurysm detected through screening. Aneurysm Detection and Management (ADAM) Veterans Affairs Cooperative Study Group. Ann Intern Med. 1997; 126: 441-449.
2. Baumgartner I, Hirsch AT, Abola MT, Cacoub PP, Poldermans D, Steg PG, Creager MA, Bhatt DL; REACH Registry investigators. Cardiovascular risk profile and outcome of patients with abdominal aortic aneurysm in out-patients with atherothrombosis: data from the Reduction of Atherothrombosis for Continued Health (REACH) Registry. J Vasc Surg. 2008; 48: 808-814. doi: 10.1016/j.jvs.2008.05.026.
3. Lederle FA, Johnson GR, Wilson SE, Chute EP, Hye RJ, Makaroun MS, Barone GW, Bandyk D, Moneta GL, Makhoul RG. The aneurysm detection and management study screening program: validation cohort and final results. Aneurysm Detection and Management Veterans Affairs Cooperative Study Investigators. Arch Intern Med. 2000; 160: 1425-1430.
4. Lindholt JS, Juul S, Fasting H, Henneberg EW. Screening for abdominal aortic aneurysms: single centre randomised controlled trial. BMJ. 2005; 330: 750. doi: 10.1136/bmj.38369.620162.82.
5. Glimåker H, Holmberg L, Elvin A, Nybacka O, Almgren B, Björck CG, Eriksson I. Natural history of patients with abdominal aortic aneurysm. Eur J Vasc Surg. 1991; 5: 125-130.
6. Lederle FA, Johnson GR, Wilson SE, Ballard DJ, Jordan WD Jr, Blebea J, Littooy FN, Freischlag JA, Bandyk D, Rapp JH, Salam AA; Veterans Affairs Cooperative Study #417 Investigators. Rupture rate of large abdominal aortic aneurysms in patients refusing or unfit for elective repair. JAMA. 2002; 287: 2968-2972.
7. Lindholt JS, Sogaard R, Laustsen. Prognosis of ruptured abdominal aortic aneurysms in Denmark from 1994-2008. Clin Epidemiol. 2012; 4: 111-113. doi: 10.2147/CLEP.S31098.
8. Nicholls SC, Gardner JB, Meissner MH, Johansen HK. Rupture in small abdominal aortic aneurysms. J Vasc Surg. 1998; 28: 884-888.
9. Iribarren C, Darbinian JA, Go AS, Fireman BH, Lee CD, Grey DP. Traditional and novel risk factors for clinically diagnosed abdominal aortic aneurysm: the Kaiser multiphasic health checkup cohort study. Ann Epidemiol. 2007; 17: 669-678. doi: 10.1016/j.annepidem.2007.02.004.
10. Pleumeekers HJ, Hoes AW, van der Does E, van Urk H, Hofman A, de Jong PT, Grobbee DE. Aneurysms of the abdominal aorta in older adults. The Rotterdam Study. Am J Epidemiol. 1995; 142: 1291-1299.
11. Kent KC, Zwolak RM, Egorova NN, Riles TS, Manganaro A, Moskowitz AJ, Gelijns AC, Greco G. Analysis of risk factors for abdominal aortic aneurysm in a cohort of more than 3 million individuals. J Vasc Surg. 2010; 52: 539-548. doi: 10.1016/j.jvs.2010.05.090.
12. Lederle FA The strange relationship between diabetes and abdominal aortic aneurysm. Eur J Vasc Endovasc Surg. 2012; 43: 254-256. doi: 10.1016/j.ejvs.2011.12.026.
13. Vega de Céniga M, Gómez R, Estallo L et al. Growth rate and associated factors in small abdominal aortic aneurysms. Eur J Vasc Endovasc Surg Off J Eur Soc Vasc Surg. 2006; 31: 231-236. doi: 10.1016/j.ejvs.2005.10.007.
14. De Rango P, Farchioni L, Fiorucci B, Lenti M. Diabetes and abdominal aortic aneurysms. Eur J Vasc Endovasc Surg. 2014; 47: 243-261. doi: 10.1016/j.ejvs.2013.12.007.
15. Shah AD, Langenberg C, Rapsomaniki E, Denaxas S, Pujades-Rodriguez M, Gale CP, Deanfield J, Smeeth L, Timmis A, Hemingway H. Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1·9 million people. Lancet Diabetes Endocrinol. 2015; 3: 105-113. doi: 10.1016/S2213-8587(14)70219-0.
16. Dua MM, Miyama N, Azuma J, Schultz GM, Sho M, Morser J, Dalman RL. Hyperglycemia modulates plasminogen activator inhibitor-1 expression and aortic diameter in experimental aortic aneurysm disease. Surgery. 2010; 148: 429-435. doi: 10.1016/j.surg.2010.05.014.
17. Thompson A, Cooper JA, Fabricius M, Humphries SE, Ashton HA, Hafez H. An analysis of drug modulation of abdominal aortic aneurysm growth through 25 years of surveillance. J Vasc Surg. 2010; 52: 55-61.e2. doi: 10.1016/j.jvs.2010.02.012.
18. De Vriese AS, Verbeuren TJ, Van de Voorde J, Lameire NH, Vanhoutte PM. Endothelial dysfunction in diabetes. Br J Pharmacol. 2000; 130: 963-974. doi:10.1038/sj.bjp.0703393.
19. Stehouwer CDA, Henry RMA, Ferreira I. Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease. Diabetologia. 2008; 51: 527-539. doi: 10.1007/s00125-007-0918-3.
20. Niskanen L, Siitonen O, Suhonen M, Uusitupa MI. Medial artery calcification predicts cardiovascular mortality in patients with NIDDM. Diabetes Care. 1994; 17: 1252-1256.
21. Preil SA, Kristensen LP, Beck HC, Jensen PS, Nielsen PS, Steiniche T, Bjørling-Poulsen M, Larsen MR, Hansen ML, Rasmussen LM. Quantitative proteome analysis reveals increased content of basement membrane proteins in arteries from patients with type 2 diabetes mellitus and lower levels among metformin users. Circ Cardiovasc Genet. 2015; 8: 727-735. doi: 10.1161/CIRCGENETICS.115.001165.
22. Takemoto M, Yokote K, Nishimura M, Shigematsu T, Hasegawa T, Kon S, Uede T, Matsumoto T, Saito Y, Mori S. Enhanced expression of osteopontin in human diabetic artery and analysis of its functional role in accelerated atherogenesis. Arterioscler Thromb Vasc Biol. 2000; 20: 624-628.
23. Olesen P, Ledet T, Rasmussen LM. Arterial osteoprotegerin: increased amounts in diabetes and modifiable synthesis from vascular smooth muscle cells by insulin and TNF-alpha. Diabetologia. 2005; 48: 561-568. doi: 10.1007/s00125-004-1652-8.
24. Cangemi C, Skov V, Poulsen MK, et al. Fibulin-1 is a marker for arterial extracellular matrix alterations in type 2 diabetes. Clin Chem. 2011; 57: 1556-1565. doi: 10.1373/clinchem.2011.162966.
25. Jensen LO, Thayssen P, Mintz GS, Maeng M, Junker A, Galloe A, Christiansen EH, Hoffmann SK, Pedersen KE, Hansen HS, Hansen KN. Intravascular ultrasound assessment of remodelling and reference segment plaque burden in type-2 diabetic patients. Eur Heart J. 2007; 28: 1759-1764. doi: 10.1093/eurheartj/ehm175.
26. Jiménez-Quevedo P, Suzuki N, Corros C, Ferrer C, Angiolillo DJ, Alfonso F, Hernández-Antolín R, Bañuelos C, Escaned J, Fernández C, Costa M, Macaya C, Bass T, Sabaté M. Vessel shrinkage as a sign of atherosclerosis progression in type 2 diabetes: a serial intravascular ultrasound analysis. Diabetes. 2009; 58: 209-214. doi: 10.2337/db08-0376.
27. Grøndal N, Søgaard R, Henneberg EW, Lindholt JS. The Viborg Vascular (VIVA) screening trial of 65-74 year old men in the central region of Denmark: study protocol. Trials. 2010; 11: 67. doi: 10.1186/1745-6215-11-67.
28. Grøndal N, Søgaard R, Lindholt JS. Baseline prevalence of abdominal aortic aneurysm, peripheral arterial disease and hypertension in men aged 65-74 years from a population screening study (VIVA trial). Br J Surg. 2015; 102: 902-906. doi: 10.1002/bjs.9825.
29. Grøndal N, Bramsen MB, Thomsen MD, Rasmussen CB, Lindholt JS. The cardiac cycle is a major contributor to variability in size measurements of abdominal aortic aneurysms by ultrasound. Eur J Vasc Endovasc Surg. 2012; 43: 30-33. doi: 10.1016/j.ejvs.2011.09.025.
30. Carlsen S, Petersen PH, Skeie S, Skadberg Ø, Sandberg S. Within-subject biological variation of glucose and HbA(1c) in healthy persons and in type 1 diabetes patients. Clin Chem Lab Med. 2011; 49: 1501-1507. doi: 10.1515/CCLM.2011.233.
31. Golledge J, Karan M, Moran CS, Muller J, Clancy P, Dear AE, Norman PE. Reduced expansion rate of abdominal aortic aneurysms in patients with diabetes may be related to aberrant monocyte-matrix interactions. Eur Heart J. 2008; 29: 665-672. doi: 10.1093/eurheartj/ehm557.
32. Aronson D. Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes. J Hypertens. 2003; 21: 3-12. doi: 10.1097/01.hjh.0000042892.24999.92.
33. Miyama N, Dua MM, Yeung JJ, Schultz GM, Asagami T, Sho E, Sho M, Dalman RL. Hyperglycemia limits experimental aortic aneurysm progression. J Vasc Surg. 2010; 52: 975-983. doi: 10.1016/j.jvs.2010.05.086.